ODDWAYINTERNATIONAL ANNOUNCES ADDITION OF VELPATASVIR AND SOFOSBUVIR IN THEIR PRODUCT CATALOGUE
05/26/2017

“Indian Generic Velpatasvir and Sofosbuvir, Hepatitis Medications by Zydus Heptiza”

Online PR News – 26-May-2017 – singapore – Oddway International, a wholesale pharmaceutical supplier, distributor and illustrious wholesaler for its proficiency in the industry introduces yet another efficient medication; SoviHep V manufactured by Zydus Heptiza containing Sofosbuvir & Velpatasvir recently approved by the Indian FDA, in their comprehensive spread of product listing.

Combination of Velpatasvir + Sofosbuvir, Internationally sold under the trade name Epclusa available in a pack of 28 tablets, used in the treatment of adults with genotype 1-6 chronic Hepatitis C Virus infection. One of the two drugs in SoviHep V is Sofosbuvir 400mg, which is a nucleotide polymerse inhibitor, and the other is Velpatasvir 100mg which is an NS5A (Hepatitis C Virus non-structural protein 5A) inhibitor. Sofosbuvir interferes with the reproduction of genetic material of the Hepatitis C. Velpatasvir works by interfering with the protein needed by the virus. Oddway International pride of more than twenty categories of product classification with hundreds of quality products in each category offered at the reasonable price. They take pleasure in ‘quality control’ and ‘quality assurance’ to offer their local and global customers improved health and wellness with their quality medicine.

About Oddway International

Oddway International is an industry which boasts itself for staying at the advanced of Pharmaceutical health product technology. Since its establishment, it has been at the forefront of providing the greatest quality of healthy living products for its customers globally. It is devoted to making healthcare available to all, improving the overall performance and health of its buyers through continuous innovation, research and hard work.

For more information,please visit: www.oddwayinternational.com